Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1476 

    Article Cited by others

ORIGINAL ARTICLE

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

Babatin Mohammed A, AlGhamdi Abdullah S, Assiri Abdullah M, AlBiladi Haziz, AlOthmani Hammad S, Mogharbel Mohammed H, Mahallawi Wedad, Asselah Tarik, Sanai Faisal M

Year : 2019| Volume: 25| Issue : 1 | Page no: 55-60

   This article has been cited by
 
1 Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia
AhmedSaqer Alotaibi, Nour Shamas, UmairUddin Ansari, FaisalM Sanai, Ali Alshahrani, AhmedIbrahim Fathelrahman, MohammedAli Aseeri
Journal of Pharmacy And Bioallied Sciences. 2021; 13(3): 317
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection
LA Lemoine, M* Segarra-Newnham
Annals of Clinical Gastroenterology and Hepatology. 2019; 3(1): 027
[Pubmed]  [Google Scholar] [DOI]

 

Read this article